Slides: Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?Slides (presentation) - Apr. 15, 2019 - Melbourne, Australia - Mark Cooper, MD Monash University Melbourne, Australia - PACE-CME symposium held during ISN-WCN 2019
Slides as educational service to PACE members and meeting participants
This lecture was part of a CME-accredited symposium SGLT2 inhibition in CKD: Discussing the key questions and evidence held during ISN-WCN 2019 in Melbourne, Australia.
The presentation was prepared and held by Prof. Cooper, the inaugural Head of the Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia
This CME symposium was supported by an unrestricted educational grant from Boehringer Ingelheim/Lilly.